FitBodySecrets

Cheryl Nasso

Welcome to FitBodySecrets with Cheryl Nasso! Cheryl Nasso Is a 5 times CrossFit Games athlete and owner of FitBodyRX. This podcast was created to offer a platform for real solutions for people looking to achieve fitness and fat loss while also finding the answers to some of the most common nutrition and training questions. We hope to educate, entertain and inspire more people to go after their goals! https://www.facebook.com/cheryl.nasso https://www.instagram.com/cherylnasso

  1. MAR 23

    Why Women 35+ Should Think Twice About GLP-1s for Fat Loss

    GLP-1 medications like Ozempic, Wegovy, and Tirzepatide are becoming increasingly popular for rapid weight loss - but are they the right solution for active women who care about body composition, strength, and long-term sustainability? In this episode, we break down what these medications actually do, who they’re designed for, and the potential risks that often get overlooked - especially for women 35+ navigating fat loss, performance, and hormone changes. This is not about fear or judgment- it’s about understanding the full picture so you can make informed decisions about your body. What You’ll Learn in This EpisodeWhy GLP-1 medications are so appealing for fat lossWhat these drugs actually do in the body (and what they don’t do)Who truly benefits most from GLP-1 medicationsThe difference between adherence vs dependenceThe risk of muscle loss during rapid weight lossHow under-eating can negatively impact performance and recoveryWhy many women experience rebound weight gain after stoppingThe return of hunger and food noise post-medicationThe difference between correlation vs causation in hormone and inflammation improvementsWhy appetite suppression doesn’t replace the need for nutrition and behavior skillsThe long-term sustainability and financial considerations of GLP-1 useWhen these medications can be helpful (when used appropriately)Key TakeawaysGLP-1 medications do not directly burn fat—they reduce appetite, making it easier to maintain a calorie deficitWithout intentional strength training and adequate protein intake, muscle loss is a real riskMany of the “benefits” people report (better hormones, less inflammation, more energy) are largely due to weight loss itself—not the drugIf no sustainable habits are built, coming off these medications often leads to rebound weight gain and return of food noiseLong-term success comes from building skills—not relying on appetite suppressionWho These Medications May Be Appropriate ForIndividuals with Type 2 diabetesThose with obesity and significant metabolic dysfunctionIndividuals struggling with severe food noise or binge eating patterns For others—especially active women focused on body composition—there may be more sustainable and effective long-term approaches. References & ResearchWilding JPH, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine.Jastreboff AM, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine.Weinheimer EM, Sands LP, Campbell WW. (2010). A systematic review of the effects of weight loss on lean body mass in older adults.Murphy CH, et al. (2014). Higher protein intake preserves lean mass during weight loss in older adults.Hall KD, et al. (2016). Persistent metabolic adaptation following weight loss and implications for weight regain.

    34 min
5
out of 5
25 Ratings

About

Welcome to FitBodySecrets with Cheryl Nasso! Cheryl Nasso Is a 5 times CrossFit Games athlete and owner of FitBodyRX. This podcast was created to offer a platform for real solutions for people looking to achieve fitness and fat loss while also finding the answers to some of the most common nutrition and training questions. We hope to educate, entertain and inspire more people to go after their goals! https://www.facebook.com/cheryl.nasso https://www.instagram.com/cherylnasso

You Might Also Like